ribociclib,abemaciclib
novartis,eli lilly
['natalee', ' ribo', 'breast', 'abema', 'ribociclib', 'abemaciclib']
new advances for early-stage hr+ her2neg. #breastcancer! ribociclib will surely become a new soc in the adjuvant setting, along with abemaciclib but with some crucial differences in target population. longer follow up needed to confirm clinical benefit #natalee 
Medical Oncologist @hospitalclinic. Post-Doc Researcher @IDIBAPS focused on #breastcancer #intrinsicsubtypes #immunotherapy #HER2low. Adjunct Prof @UniBarcelona